Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

100%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_4

20%

Ph not_applicable

40%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Other(2)

Detailed Status

Completed2

unknown2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (25.0%)

Phase 41 (25.0%)

N/A2 (50.0%)

Trials by Status

terminated120%

completed240%

unknown240%

Recent Activity

0 active trials

Showing 5 of 5

completed

Retrospective Cohort Study on the Impact of PDL Treatment History on the Efficacy of HMME-PDT in Treating PWS Children

NCT06875492

completedphase_4

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

NCT04677712

unknownnot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT06875492

Retrospective Cohort Study on the Impact of PDL Treatment History on the Efficacy of HMME-PDT in Treating PWS Children

Completed

NCT04677712Phase 4

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

Completed

NCT05771311Not Applicable

KTP Laser vs Pulsed Dye Laser for Port-Wine Stains

Unknown

NCT02458976Not Applicable

Pulsed-dye Laser Treatment Prior to Surgical Excision

Unknown

NCT00592319Phase 2

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Terminated

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5